Papers

4

Total Citations

93

H-Index

4

About

Dr. Massimo Chiarugi is a pioneering force in surgical robotics and medical device innovation, with a research portfolio that bridges cutting-edge bioengineering and clinical colorectal surgery. His most transformative contribution is the development of a fully implantable robotic device for intraperitoneal drug delivery, refillable by ingestible capsules—a breakthrough with 64 citations that promises to revolutionize type 1 diabetes management by restoring blood glucose homeostasis. This work exemplifies his commitment to creating autonomous physiological replacement systems. In parallel, Dr. Chiarugi is a leading authority on minimally invasive colorectal surgery, having authored landmark multicenter European studies. His 2022 analysis of operation duration’s impact on outcomes after minimally-invasive right colectomy (15 citations) and his 2023 propensity-matched comparison of robotic versus laparoscopic intracorporeal anastomosis (9 citations) provide critical evidence for optimizing surgical techniques. He has also investigated conversion risks during minimally invasive cancer surgery (5 citations), offering actionable insights to reduce adverse outcomes. Dr. Chiarugi’s unique ability to integrate advanced robotics with rigorous clinical research positions him at the forefront of next-generation surgical care, directly improving patient lives through both implantable technologies and refined operative protocols.

Research Focus

Key Achievements

4
H-Index
4
Papers
93
Total Citations
23
Avg Citations/Paper
🏆 Most Cited Paper
A fully implantable device for intraperitoneal drug delivery refilled by ingestible capsules
64 citations · 2021
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 67
🏛 Institutions: Ospedale Cisanello, Azienda Ospedaliera Universitaria Pisana

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago